Associated response in bone mineral density and atherogenic lipid profile during treatment with two different selective estrogen receptor modulators: levormeloxifene and raloxifene

Author： Bloch-Thomsen A.   Silvestri S.   Christiansen C.   Bjarnason N. H.  

Publisher： Informa Healthcare

ISSN： 1473-0804

Source： Climacteric, Vol.6, Iss.2, 2003-06, pp. : 159-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phytoestrogens: the ''natural'' selective estrogen receptor modulators?

By Brzezinski A.   Debi A.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 85, Iss. 1, 1999-07 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Pharmacology and clinical applications of selective estrogen receptor modulators

By Nath A.   Sitruk-Ware R.  

Climacteric, Vol. 12, Iss. 3, 2009-06 ,pp. : 188-205

Informa Healthcare

Access to resources Recommend Favorite

Estrogen receptor gene polymorphisms in a group of postmenopausal Turkish women: association with bone mineral density

By Yavuz D. G.  

Climacteric, Vol. 15, Iss. 4, 2012-08 ,pp. : 368-373

Informa Healthcare

Access to resources Recommend Favorite

Selective estrogen receptor modulators and risk for coronary heart disease

By Cano A.   Hermenegildo C.   Oviedo P.   Tarin J. J.  

Climacteric, Vol. 10, Iss. 2, 2007-04 ,pp. : 97-111

Informa Healthcare

Access to resources Recommend Favorite

Urogenital effects of selective estrogen receptor modulators: a systematic review

By Albertazzi P.   Sharma S.  

Climacteric, Vol. 8, Iss. 3, 2005-09 ,pp. : 214-220

Informa Healthcare

Access to resources Recommend Favorite